Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.

MLA

Zhang, Guan-Dong, et al. “Mitochondria-Targeted Ruthenium Complexes Can Be Generated in Vitro and in Living Cells to Target Triple-Negative Breast Cancer Cells by Autophagy Inhibition.” Journal of Inorganic Biochemistry, vol. 256, July 2024, p. 112574. EBSCOhost, https://doi.org/10.1016/j.jinorgbio.2024.112574.

APA

Zhang, G.-D., Wang, M.-M., Su, Y., Fang, H., Xue, X.-L., Liu, H.-K., & Su, Z. (2024). Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition. Journal of Inorganic Biochemistry, 256, 112574. https://doi.org/10.1016/j.jinorgbio.2024.112574

Chicago

Zhang, Guan-Dong, Meng-Meng Wang, Yan Su, Hongbao Fang, Xu-Ling Xue, Hong-Ke Liu, and Zhi Su. 2024. “Mitochondria-Targeted Ruthenium Complexes Can Be Generated in Vitro and in Living Cells to Target Triple-Negative Breast Cancer Cells by Autophagy Inhibition.” Journal of Inorganic Biochemistry 256 (July): 112574. doi:10.1016/j.jinorgbio.2024.112574.